<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BJI</journal-id>
<journal-id journal-id-type="hwp">spbji</journal-id>
<journal-title>Journal of Infection Prevention</journal-title>
<issn pub-type="ppub">1757-1774</issn>
<issn pub-type="epub">1757-1782</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1757177413476125</article-id>
<article-id pub-id-type="publisher-id">10.1177_1757177413476125</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Peer reviewed articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A systematic evaluation of a peracetic-acid-based high performance disinfectant</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Humphreys</surname><given-names>Paul N</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
<xref ref-type="corresp" rid="corresp1-1757177413476125">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Finan</surname><given-names>Peter</given-names></name>
<xref ref-type="aff" rid="aff2-1757177413476125">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rout</surname><given-names>Simon</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hewitt</surname><given-names>James</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Thistlethwaite</surname><given-names>Peter</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Barnes</surname><given-names>Sophie</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pilling</surname><given-names>Sally</given-names></name>
<xref ref-type="aff" rid="aff1-1757177413476125">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1757177413476125"><label>1</label>Hygiene and Disinfection Centre, School of Applied Science, University of Huddersfield, Huddersfield, HD6 3SW, UK</aff>
<aff id="aff2-1757177413476125"><label>2</label>MTP Innovation Ltd, Huddersfield, UK</aff>
<author-notes>
<corresp id="corresp1-1757177413476125"><label>*</label>Hygiene and Disinfection Centre, School of Applied Science, University of Huddersfield, Huddersfield, HD6 3SW, UK. Email: <email>p.n.humphreys@hud.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>14</volume>
<issue>4</issue>
<fpage>126</fpage>
<lpage>131</lpage>
<history>
<date date-type="accepted">
<day>1</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">Infection Prevention Society</copyright-holder>
</permissions>
<abstract>
<p>The importance of environmental contamination in the spread of healthcare associated infections (HAI) has generated a need for high performance disinfectants. Currently chlorine-based disinfectants are the products of choice, a position reflected in UK guidance. The aim of this research was to evaluate a peracetic acid (PAA) generating disinfectant to determine if it provided a realistic alternative to commonly used chlorine-based disinfectants. The European standards framework was employed in this study and enhanced where appropriate by reducing the contact times, increasing the organic and microbial challenge, and changing the organisms involved. When tested against bacteria and spores PAA provided similar or better performance than currently employed levels of chlorine. This was particularly the case in the presence of an organic challenge or dried surface contamination. The chlorine disinfectants only demonstrated superior performance in the case of fungal spores. These results suggest that PAA generating products provide an effective alternative to chlorine-based products up to 10,000 ppm free available chlorine. These products have superior performance in situations with spore borne, surface contamination and high organic challenge. In cases where filamentous fungi are a concern, high levels of PAA (&gt;5,000 ppm) would be required to match the performance of chlorine based disinfectants.</p>
</abstract>
<kwd-group>
<kwd>Bacterial contamination</kwd>
<kwd>cleaning</kwd>
<kwd><italic>Clostridium difficile</italic></kwd>
<kwd>disinfection</kwd>
<kwd>healthcare-associated infections</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1757177413476125" sec-type="intro">
<title>Introduction</title>
<p>Environmental contamination has been implicated in the spread of healthcare associated infections (HAI) (<xref ref-type="bibr" rid="bibr14-1757177413476125">Dancer and Carling, 2010</xref>; <xref ref-type="bibr" rid="bibr50-1757177413476125">Wang et al, 2010</xref>; <xref ref-type="bibr" rid="bibr51-1757177413476125">Weber et al, 2010</xref>; <xref ref-type="bibr" rid="bibr10-1757177413476125">Carling and Bartley, 2010</xref>), and consequently environmental cleaning can contribute significantly to the control of HAI (<xref ref-type="bibr" rid="bibr13-1757177413476125">Dancer, 2009</xref>; <xref ref-type="bibr" rid="bibr15-1757177413476125">Dancer et al., 2009</xref>; <xref ref-type="bibr" rid="bibr40-1757177413476125">Otter et al, 2011</xref>). Of the micro-organisms associated with HAI, <italic>Clostridium difficile</italic> (<xref ref-type="bibr" rid="bibr30-1757177413476125">Kim et al., 1981</xref>; <xref ref-type="bibr" rid="bibr34-1757177413476125">Malamou-Ladas et al, 1983</xref>) represents the most significant disinfection challenge due to: the innate disinfection resistance of <italic>C. difficile</italic> spores (<xref ref-type="bibr" rid="bibr47-1757177413476125">Tumah, 2009</xref>; <xref ref-type="bibr" rid="bibr33-1757177413476125">Maillard, 2011</xref>), their environmental persistence (<xref ref-type="bibr" rid="bibr31-1757177413476125">Kramer et al, 2006</xref>), the large numbers of spores excreted (<xref ref-type="bibr" rid="bibr36-1757177413476125">Mulligan et al, 1979</xref>) and their low infective dose (<xref ref-type="bibr" rid="bibr44-1757177413476125">Sambol et al, 2001</xref>). The requirement for disinfectants able to inactivate <italic>C. difficile</italic> spores, and the limited number of sporicides (<xref ref-type="bibr" rid="bibr32-1757177413476125">Lambert, 2004</xref>; <xref ref-type="bibr" rid="bibr47-1757177413476125">Tumah, 2009</xref>), has resulted in the domination of chlorine-based products (<xref ref-type="bibr" rid="bibr49-1757177413476125">Vohra and Poxton, 2011</xref>; <xref ref-type="bibr" rid="bibr21-1757177413476125">Fraise, 2011</xref>). This dominance is reflected in UK guidance (<xref ref-type="bibr" rid="bibr18-1757177413476125">Department of Health (DH) and Health Protection Agency (HPA), 2009</xref>; <xref ref-type="bibr" rid="bibr18-1757177413476125">HPA, 2009</xref>; <xref ref-type="bibr" rid="bibr42-1757177413476125">Pratt et al, 2007</xref>) where products delivering 1,000 ppm free available chlorine (FAC) are recommended for cleaning associated with patients with <italic>C. difficile</italic> infections (CDI); in the presence of blood 10,000 ppm FAC is recommended (<xref ref-type="bibr" rid="bibr17-1757177413476125">DH, 1998</xref>). Chlorine-based products have disadvantages including: respiratory irritation (<xref ref-type="bibr" rid="bibr21-1757177413476125">Fraise, 2011</xref>), reduced activity in the presence of organic matter (<xref ref-type="bibr" rid="bibr35-1757177413476125">McDonnell and Russell, 1999</xref>; <xref ref-type="bibr" rid="bibr33-1757177413476125">Maillard, 2011</xref>) and incompatibility with microfiber cloths (<xref ref-type="bibr" rid="bibr37-1757177413476125">National Patient Safety Agency, 2009</xref>; <xref ref-type="bibr" rid="bibr23-1757177413476125">Gant et al, 2010</xref>). There is also evidence that chlorine-based disinfectants have limited efficacy against environmental <italic>C. difficile</italic> contamination (<xref ref-type="bibr" rid="bibr1-1757177413476125">Ali et al., 2011</xref>; <xref ref-type="bibr" rid="bibr24-1757177413476125">Goldenberg et al., 2012</xref>).</p>
<p>Peroxygen compounds potentially provide a viable alternative to chlorine, given their broad spectrum biocidal activity (<xref ref-type="bibr" rid="bibr35-1757177413476125">McDonnell and Russell, 1999</xref>; <xref ref-type="bibr" rid="bibr22-1757177413476125">Fraise et al., 2004</xref>). Peroxygen-based disinfectants are generally employed in instrument decontamination (<xref ref-type="bibr" rid="bibr27-1757177413476125">Hernández et al., 2003a</xref>,<xref ref-type="bibr" rid="bibr28-1757177413476125">b</xref>; <xref ref-type="bibr" rid="bibr48-1757177413476125">Vizcaino-Alcaide et al, 2003</xref>), and have received limited attention as environmental disinfectants (<xref ref-type="bibr" rid="bibr11-1757177413476125">Carter and Barry, 2011</xref>; <xref ref-type="bibr" rid="bibr46-1757177413476125">Speight et al., 2011</xref>) apart from their use in wipes (<xref ref-type="bibr" rid="bibr11-1757177413476125">Carter and Barry, 2011</xref>). However, peroxygen compounds such as peracetic acid (PAA) can be easily generated through the aqueous reaction of tetraacetylethylenediamine (TAED) and a peroxide generator (<xref ref-type="bibr" rid="bibr16-1757177413476125">Davies and Deary, 1991</xref>; <xref ref-type="bibr" rid="bibr41-1757177413476125">Pan et al., 1999</xref>).</p>
<p>The objective of this study was to evaluate the disinfection capabilities of a PAA generating powder blend delivered in a dissolving sachet. The evaluation was performed by comparison with commercial sodium dichloroisocyanurate (NaDCC) tablets generating the two recommended levels of FAC, (1,000 ppm (<xref ref-type="bibr" rid="bibr18-1757177413476125">DH and HPA, 2009</xref>; <xref ref-type="bibr" rid="bibr42-1757177413476125">Pratt et al., 2007</xref>) and 10,000 ppm (<xref ref-type="bibr" rid="bibr17-1757177413476125">DH, 1998</xref>)). NaDCC in contact with water generates free FAC via hypochlorous acid, with a reservoir of FAC being maintained by solution phase, chlorinated isocyanurates (<xref ref-type="bibr" rid="bibr12-1757177413476125">Clasen and Edmondson, 2006</xref>). This reservoir of FAC generated by NaDCC contributes to its improved performance over and above hypochlorite based products (<xref ref-type="bibr" rid="bibr20-1757177413476125">Fawley et al, 2007</xref>). An NaDCC-based chlorine generating system was chosen for this investigation owing to its proven advantages over hypochlorite (<xref ref-type="bibr" rid="bibr20-1757177413476125">Fawley et al, 2007</xref>) and its common usage in the NHS, for example (<xref ref-type="bibr" rid="bibr2-1757177413476125">Bailey, 2009</xref>; <xref ref-type="bibr" rid="bibr3-1757177413476125">Bloomfield, 2011</xref>; <xref ref-type="bibr" rid="bibr38-1757177413476125">NHS Wirral, 2010</xref>).This comparison employed the European standard disinfection tests (<xref ref-type="bibr" rid="bibr8-1757177413476125">BSI, 2006</xref>; <xref ref-type="bibr" rid="bibr29-1757177413476125">Humphreys, 2011</xref>) modified to increase the disinfection demand posed.</p>
</sec>
<sec id="section2-1757177413476125" sec-type="methods">
<title>Methods</title>
<sec id="section3-1757177413476125">
<title>Testing strategy</title>
<p>The European standards framework (<xref ref-type="bibr" rid="bibr8-1757177413476125">BSI, 2006</xref>) for the testing of disinfectants was used as a basis for this investigation. The tests employed are all commonly used to verify the effectiveness of disinfectants employed in healthcare settings. Two testing approaches were employed; firstly suspension tests to determine basic bactericidal, (BS EN 1276 (<xref ref-type="bibr" rid="bibr4-1757177413476125">BSI, 1997</xref>)), fungicidal (BS EN 1650 (<xref ref-type="bibr" rid="bibr9-1757177413476125">BSI, 2008</xref>)) and sporicidal (BS EN 13704 (<xref ref-type="bibr" rid="bibr6-1757177413476125">BSI, 2002</xref>)) activity and secondly, surface tests (BS EN 13697(<xref ref-type="bibr" rid="bibr5-1757177413476125">BSI, 2001</xref>)) to determine the surface bactericidal and sporicidal activity of the two disinfectants. In order to pass these standard tests a disinfectant has to generate the required log reduction in the specified contact time in the presence of the specified interfering substance (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>). The organisms specified by the standards (<xref ref-type="bibr" rid="bibr8-1757177413476125">BSI, 2006</xref>) are chosen to be representative of a wide range of pathogenic organisms relevant to healthcare settings. In suspension tests, a suspension of organisms or spores is mixed with a sample of interfering substance (see below) and then with the disinfectant under test. The mixture is then incubated at 20°C for the specified contact time (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>), and following incubation a sample of the test mixture is transferred to a neutralisation solution which stops the action of the disinfectant and preserves the contact time. Following neutralisation the number of surviving organisms or spores is determined employing the media and incubation conditions specified in the relevant standard. The tests include a range of validations including a neutralisation test, which ensure the neutralisation solution is effective.</p>
<table-wrap id="table1-1757177413476125" position="float">
<label>Table 1.</label>
<caption>
<p>Modifications to standard tests</p>
</caption>
<graphic alternate-form-of="table1-1757177413476125" xlink:href="10.1177_1757177413476125-table1.tif"/>
<table frame="hsides" rules="cols">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left" colspan="2">1276<hr/></th>
<th align="left" colspan="2">1650<hr/></th>
<th align="left" colspan="2">13704<hr/></th>
<th align="left" colspan="2">13697<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Standard</th>
<th align="left">Additional</th>
<th align="left">Standard</th>
<th align="left">Additional</th>
<th align="left">Standard</th>
<th align="left">Additional</th>
<th align="left">Standard</th>
<th align="left">Additional</th>
</tr>
</thead>
<tbody>
<tr>
<td>Organisms</td>
<td><italic>E. coli</italic><break/><italic>E.hirae</italic><break/><italic>S. aureus</italic><break/><italic>P. aeruginosa</italic></td>
<td>N/A</td>
<td><italic>A. brasiliensis</italic><break/><italic>C. albicans</italic></td>
<td>N/A</td>
<td><italic>B. subtilis</italic></td>
<td><italic>C. difficile</italic></td>
<td><italic>E. coli</italic><break/><italic>E.hirae</italic><break/><italic>S. aureus</italic><break/><italic>P. aeruginosa</italic></td>
<td><italic>B. subtilis</italic> (Spores)</td>
</tr>
<tr>
<td>Interfering substances</td>
<td>Clean and dirty</td>
<td>Enhanced dirty</td>
<td>Clean and dirty</td>
<td>N/A</td>
<td>Clean and dirty</td>
<td>Enhanced dirty</td>
<td>Clean and dirty</td>
<td>Enhanced dirty</td>
</tr>
<tr>
<td>Contact time</td>
<td>5 min</td>
<td>30 sec upwards</td>
<td>15 min</td>
<td>N/A</td>
<td>60 min</td>
<td>30 sec upwards</td>
<td>5 min</td>
<td>30 sec upwards</td>
</tr>
<tr>
<td>Bacterial / fungal/Spore challenge</td>
<td>10<sup>7</sup> cfu/ml</td>
<td>N/A</td>
<td>10<sup>6</sup> cfu/ml</td>
<td>N/A</td>
<td>10<sup>5</sup> cfu/ml</td>
<td>10<sup>7</sup> cfu/ml <italic>B. subtilis</italic></td>
<td>10<sup>6</sup> cfu/ surface</td>
<td>10<sup>4</sup> cfu/ surface</td>
</tr>
<tr>
<td>Pass criteria (log reduction)</td>
<td>5</td>
<td>N/A</td>
<td>4</td>
<td>N/A</td>
<td>3</td>
<td>N/A</td>
<td>4 (Bacteria) 3 (Fungi)</td>
<td>N/A</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In the surface test BS EN 13697 (<xref ref-type="bibr" rid="bibr5-1757177413476125">BSI, 2001</xref>) a suspension of bacteria or spores is mixed with a sample of interfering substance (see below) and then dried onto a stainless steel surface prior to the application of the disinfectant under test. Following the specified contact time the surviving organisms or spores are recovered by agitation on a bed of glass beads in the presence of a neutraliser. Following neutralisation the number of surviving organisms or spores is determined employing the media and incubation conditions specified in the relevant standard. The efficacy of the disinfectant is determined by comparison with a set of water controls treated in the same manner as the test surfaces. As with the suspension tests, a range of validations are performed including a neutralisation test, which ensure the neutralisation solution is effective.</p>
<p>The challenge posed by the standard suspension and surface tests was increased by increasing the amount of interfering substance (see below), reducing the contact time, employing a higher initial inoculum and changing the organism involved. The standard conditions and the relevant modifications are outlined in <xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>. Testing procedures and validations were performed as outlined in the relevant standards (<xref ref-type="bibr" rid="bibr9-1757177413476125">BSI, 2008</xref>, <xref ref-type="bibr" rid="bibr5-1757177413476125">BSI, 2001</xref>, <xref ref-type="bibr" rid="bibr6-1757177413476125">BSI, 2002</xref>, <xref ref-type="bibr" rid="bibr4-1757177413476125">BSI, 1997</xref>). Emphasis has been placed on shorter contact times than those specified in the standards, which reflects the need for a rapid disinfection impact to prevent cross contamination and the environmental survival of pathogenic micro-organisms. Tests were carried out in triplicate, on separate days and were only considered valid if the relevant validations met the criteria specified in standards.</p>
<p>No attempt was made to simulate wiping; the aim being to evaluate the products in a ‘spray and wipe’ configuration where the disinfection impact can be assessed free of the influence of mechanical action.</p>
</sec>
<sec id="section4-1757177413476125">
<title>Products</title>
<p>The PAA generating powder blend (PB) (MTP Innovations Ltd, UK) was used at a range of concentrations (20, 10, 5 and 2.5 g/l) in standard hardness water (<xref ref-type="bibr" rid="bibr4-1757177413476125">BSI, 1997</xref>). Commercial NaDCC tablets were employed to generate solutions of 1,000 ppm and 10,000ppm FAC in standard hardness water (<xref ref-type="bibr" rid="bibr4-1757177413476125">BSI, 1997</xref>) as per manufacturers’ instructions, i.e. one tablet in 2.5 litres to generate 1,000 ppm FAC and four tablets in 1.0 litre to generate 10,000 ppm FAC.</p>
</sec>
<sec id="section5-1757177413476125">
<title>Interfering substances</title>
<p>Organic matter such as blood, serum, pus and faecal material (<xref ref-type="bibr" rid="bibr43-1757177413476125">Russell, 2004</xref>), is commonly associated with microbial contamination. The presence of organic material may interfere with the action of disinfectants through either a direct reaction or via providing a protective environment for the microbes concerned (<xref ref-type="bibr" rid="bibr43-1757177413476125">Russell, 2004</xref>). Consequently many biocide tests include the presence of interfering organic substances to reflect this potential impact. In this study three levels of interfering substance have been employed to provide an increasing level of challenge to disinfectant performance. These levels – simulated clean, dirty (<xref ref-type="bibr" rid="bibr4-1757177413476125">BSI, 1997</xref>) (0.3 g/l and 3.0 g/l Bovine Serum Albumin(BSA)) and enhanced dirty conditions (<xref ref-type="bibr" rid="bibr7-1757177413476125">BSI, 2005</xref>) (3.0 g/l BSA with 3 ml/l sheep erythrocytes) – are all used in the European disinfection standards. Enhanced dirty conditions are taken from testing standards aimed at mycobactericidal activity where the presence of blood provides an additional level of organic challenge that may interfere with disinfectant activity.</p>
</sec>
<sec id="section6-1757177413476125">
<title>Determination of peracetic acid and chlorine concentrations</title>
<p>PAA and FAC concentrations were determined by iodometric titrations (<xref ref-type="bibr" rid="bibr25-1757177413476125">Greenspan and MacKellar, 1948</xref>; <xref ref-type="bibr" rid="bibr19-1757177413476125">Eaton et al, 2005</xref>).</p>
</sec>
<sec id="section7-1757177413476125">
<title>Organisms</title>
<p>The organisms employed are those outlined in the relevant European standards. Bactericidal tests were carried out against <italic>Escherichia coli</italic> (NCIMB 8879), <italic>Enterococcus hirae</italic> (NCIMB 8191), <italic>Pseudomonas aeruginosa</italic> (NCIMB 10421) and <italic>Staphylococcus aureus</italic> (NCIMB 9518). Fungicidal test were carried out against <italic>Aspergillus brasiliensis</italic> (ATCC 16404) (previously known as <italic>Aspergillus niger</italic>) and <italic>Candida albicans</italic> (ATCC 10231). <italic>Bacillus subtilis</italic> (ATCC 6633) spores (10<sup>9</sup> spores/ml) were obtained from Raven Labs Ltd, USA. Spores of <italic>C. difficile</italic> (NCTC 13366) were recovered from Fastidious Anaerobe Agar (FAA) (Lab M Ltd), supplemented with Cycloserine/Cefoxitin (Lab M Ltd). <italic>C. difficile</italic> cultures were incubated anaerobically, at 37°C for seven days. Prior to use, <italic>C. difficile</italic> spore suspensions were alcohol shocked (<xref ref-type="bibr" rid="bibr26-1757177413476125">HPA, 2012</xref>) to remove vegetative cells. Generally, <italic>B. subtilis</italic> spores were preferred as a surrogate to <italic>C. difficile</italic> spores due to their purity, safety, reduced incubation times, economy of media and ease of dispersion.</p>
</sec>
</sec>
<sec id="section8-1757177413476125" sec-type="results">
<title>Results</title>
<sec id="section9-1757177413476125">
<title>PAA determination</title>
<p>The full strength PB generated 2,000 to 2,500 ppm PAA (x– ≈ 2250 ppm) at a pH of 7.5 to 8.5 after the 20 minute dwell time specified by the manufacturer. The effect of increased dilution on PAA generation was not a linear relationship (<xref ref-type="fig" rid="fig1-1757177413476125">Figure 1</xref>) with a 50% reduction in powder loading generating an 18% reduction in PAA concentration. When prepared as per manufacturers’ instructions the 1,000 and 10,000 ppm FAC solutions were found to be on average 8% greater than specified. The NaDCC tablets generated FAC at full strength immediately following dissolution; there was no generation curve evident.</p>
<fig id="fig1-1757177413476125" position="float">
<label>Figure 1.</label>
<caption>
<p>Impact of product loading on peracetic acid generation</p>
</caption>
<graphic xlink:href="10.1177_1757177413476125-fig1.tif"/>
</fig>
</sec>
<sec id="section10-1757177413476125">
<title>Suspension tests</title>
<sec id="section11-1757177413476125">
<title>Fungicidal and yeasticidal activity</title>
<p>Under clean and dirty conditions the 2,250 ppm PAA solution and the 1,000ppm FAC generated a &gt;4 log reduction in <italic>C. albicans</italic> in 15 minutes. When tested against <italic>A. brasiliensis</italic> under clean conditions the 2,250 ppm PAA solution generated a much lower (&lt;3.34±0.00) log reduction than 1,000 ppm FAC (4.34±0.04). At 10,000ppm FAC a &gt;4 log reduction was seen in fungal spores under all conditions.</p>
</sec>
<sec id="section12-1757177413476125">
<title>Bactericidal activity</title>
<p>The 2,250 ppm PAA solution and 1,000ppm FAC demonstrated rapid bactericidal activity under enhanced dirty conditions generating a &gt;5 log reduction for all strains within 30 seconds. The PAA powder blend matched the performance of 1,000 ppm FAC at 30 seconds down to 700 ppm PAA (5g/l).</p>
</sec>
<sec id="section13-1757177413476125">
<title>Sporicidal activity</title>
<p>When challenged with a 7 log (spores/ml) (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>) <italic>B. subtilis</italic> spore load only the 2,250 ppm PAA solution and 10,000ppm FAC demonstrated significant sporicidal activity (<xref ref-type="fig" rid="fig2-1757177413476125">Figure 2</xref>). The influence of increased organic loading had a greater impact on the chlorine-based disinfectants (<xref ref-type="fig" rid="fig2-1757177413476125">Figure 2</xref>). For example under dirty and enhanced dirty conditions the PAA solution was able to generate a complete log reduction within five minutes, whereas the 10,000 ppm FAC required 30 and 60 minutes respectively to generate the same impact. When challenged with this increased spore load 1,000 ppm FAC was unable to generate any significant impact even under simulated clean conditions. When challenged with the standard spore load (5 log spores/ml) PAA solutions remained sporicidal (<xref ref-type="bibr" rid="bibr6-1757177413476125">BSI, 2002</xref>) (<xref ref-type="table" rid="table2-1757177413476125">Table 2</xref>) down to 450 ppm under enhanced dirty conditions. When <italic>C. difficile</italic> was substituted for <italic>B. subtilis</italic> in BS EN 13704 (<xref ref-type="bibr" rid="bibr6-1757177413476125">BSI, 2002</xref>) (<xref ref-type="fig" rid="fig3-1757177413476125">Figure 3</xref>) PAA had superior sporicidal activity under dirty conditions and comparable activity under enhanced dirty conditions to 10,000 ppm FAC.</p>
<fig id="fig2-1757177413476125" position="float">
<label>Figure 2.</label>
<caption>
<p>Sporicidal kill time assay</p>
</caption>
<graphic xlink:href="10.1177_1757177413476125-fig2.tif"/>
</fig>
<table-wrap id="table2-1757177413476125" position="float">
<label>Table 2.</label>
<caption>
<p>Sporicidal activity at reduced PAA levels</p>
</caption>
<graphic alternate-form-of="table2-1757177413476125" xlink:href="10.1177_1757177413476125-table2.tif"/>
<table frame="hsides" rules="cols">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Product loading (g/l)</th>
<th align="left">Conditions</th>
<th align="left">Pass/Fail</th>
<th align="left">Time required to generate a 3 log reduction<xref ref-type="table-fn" rid="table-fn1-1757177413476125">*</xref> (minutes)</th>
</tr>
</thead>
<tbody>
<tr>
<td>20</td>
<td>Enhanced dirty</td>
<td>Pass</td>
<td>0.5</td>
</tr>
<tr>
<td>10</td>
<td>Dirty</td>
<td>Pass</td>
<td>0.5</td>
</tr>
<tr>
<td/>
<td>Enhanced dirty</td>
<td>Pass</td>
<td>5</td>
</tr>
<tr>
<td>5</td>
<td>Dirty</td>
<td>Pass</td>
<td>5</td>
</tr>
<tr>
<td/>
<td>Enhanced dirty</td>
<td>Pass</td>
<td>15</td>
</tr>
<tr>
<td>2.5</td>
<td>Clean</td>
<td>Pass</td>
<td>30</td>
</tr>
<tr>
<td/>
<td>Dirty</td>
<td>Pass</td>
<td>30</td>
</tr>
<tr>
<td/>
<td>Enhanced dirty</td>
<td>Fail</td>
<td>&gt;60</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1757177413476125">
<label>*</label>
<p>A 3 log reduction in spores is the pass criteria for the BS EN 13704 sporicidal standard test</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig3-1757177413476125" position="float">
<label>Figure 3.</label>
<caption>
<p>Sporicidal activity against <italic>Clostridium difficile</italic> spore</p>
</caption>
<graphic xlink:href="10.1177_1757177413476125-fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="section14-1757177413476125">
<title>Surface tests</title>
<sec id="section15-1757177413476125">
<title>Bactericidal activity</title>
<p>Across all test strains (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>), the full strength PB (2,250 ppm PAA) produced a &gt;6 log reduction under clean and dirty conditions. Under clean conditions 1,000 ppm FAC produced a ≈3 log reduction for all bacterial strains, with no impact under dirty conditions. The performance of 10,000ppm FAC mirrored that of PAA under clean conditions; under dirty conditions the performance was 2–3 logs lower.</p>
</sec>
<sec id="section16-1757177413476125">
<title>Sporicidal activity</title>
<p>Across all organic loadings the full strength PB (2,250 ppm PAA) generated &gt;4 log reduction in <italic>B. subtilis</italic> spores within three minutes (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>), whereas 1,000ppm FAC was unable to generate any significant reduction up to five minutes contact time (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>). Similar performance was observed with 10,000ppm FAC, suggesting that the drying of spores to the surface significantly reduced its sporicidal activity.</p>
</sec>
</sec>
</sec>
<sec id="section17-1757177413476125" sec-type="discussion">
<title>Discussion</title>
<p>Bactericidal activity of the PAA generating PB matched that of 1,000 ppm FAC down to a loading generating 700 ppm PAA even under enhanced dirty conditions. Increasing the organic challenge had a limited impact on the performance of PAA when compared to 10,000 ppm FAC. The impact of organic soil was most pronounced during surface tests where the drying of soil, bacteria and spores onto surfaces significantly reduced the performance of 10,000 ppm FAC when compared to PAA (<xref ref-type="table" rid="table1-1757177413476125">Table 1</xref>).</p>
<p>The only case where FAC was seen to be more effective than PAA was the treatment of filamentous fungi. There is evidence from the literature that levels of PAA in the region of 5,000 ppm is required for the effective treatment of <italic>Aspergillus</italic> (<xref ref-type="bibr" rid="bibr39-1757177413476125">Niknejad et al, 2011</xref>; <xref ref-type="bibr" rid="bibr45-1757177413476125">Sisti et al, 2012</xref>) which is above that generated by the powder blend investigated. This data and the literature data (<xref ref-type="bibr" rid="bibr39-1757177413476125">Niknejad et al, 2011</xref>; <xref ref-type="bibr" rid="bibr45-1757177413476125">Sisti et al, 2012</xref>) suggest that <italic>A. niger</italic> spores are specifically resistant to PAA-based disinfectants. This may be due to the hydrophobic nature of <italic>A. niger</italic> spores (<xref ref-type="bibr" rid="bibr52-1757177413476125">Whitehead et al, 2011</xref>).</p>
<p>Overall the results suggest that PAA generating PBs provide a suitable substitute in situations where 1,000 and 10,000 ppm of FAC are recommended (<xref ref-type="bibr" rid="bibr18-1757177413476125">DH and HPA, 2009</xref>; <xref ref-type="bibr" rid="bibr42-1757177413476125">Pratt et al, 2007</xref>). In particular these disinfectants are suited to applications where there is significant organic soil and sporicidal activity is required, due to its relative insensitivity to organic soil. Where antifungal activity is a specific requirement, then chlorine generating products appear to be more effective, with higher levels of PAA being needed to generate significant fungicidal activity.</p>
<table-wrap id="table3-1757177413476125" position="float">
<label>Table 3.</label>
<caption>
<p>Sporicidal surface tests</p>
</caption>
<graphic alternate-form-of="table3-1757177413476125" xlink:href="10.1177_1757177413476125-table3.tif"/>
<table frame="hsides" rules="cols">
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Time (min)</th>
<th align="left" colspan="9">Log reduction in <italic>Bacillus subtilis</italic> spores ±standard deviation<hr/></th>
</tr>
<tr>
<th/>
<th align="left" colspan="3">DIFFX<hr/></th>
<th align="left" colspan="3">1,000ppm available chlorine<hr/></th>
<th align="left" colspan="3">10,000ppm available chlorine<hr/></th>
</tr>
<tr>
<th/>
<th align="left">0.3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA 3% sheep erythrocytes</th>
<th align="left">0.3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA 3% sheep erythrocytes</th>
<th align="left">0.3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA</th>
<th align="left">3gl<sup>−1</sup> BSA 3% sheep erythrocytes</th>
</tr>
</thead>
<tbody>
<tr>
<td>0.5</td>
<td>0.34±0.06</td>
<td>0.41±0.08</td>
<td>1.35±0.23</td>
<td>0.01±0.02</td>
<td>0.01±0.04</td>
<td><xref ref-type="table-fn" rid="table-fn2-1757177413476125">*</xref></td>
<td>0.19±0.23</td>
<td>0.02±0.05</td>
<td>0.22±0.11</td>
</tr>
<tr>
<td>1.5</td>
<td>1.79±0.03</td>
<td>1.81±0.04</td>
<td>1.63±0.42</td>
<td>0.07±0.01</td>
<td>0.05±0.06</td>
<td><xref ref-type="table-fn" rid="table-fn2-1757177413476125">*</xref></td>
<td>0.31±0.19</td>
<td>0.14±0.09</td>
<td>0.35±0.11</td>
</tr>
<tr>
<td>3</td>
<td>4.73±0.04</td>
<td>4.76±0.03</td>
<td>4.20±0.09</td>
<td>0.18±0.10</td>
<td>0.13±0.04</td>
<td><xref ref-type="table-fn" rid="table-fn2-1757177413476125">*</xref></td>
<td>0.37±0.22</td>
<td>0.17±0.06</td>
<td>0.51±0.12</td>
</tr>
<tr>
<td>5</td>
<td>4.73±0.04</td>
<td>4.76±0.03</td>
<td>4.20±0.09</td>
<td>0.20±0.08</td>
<td>0.39±0.31</td>
<td><xref ref-type="table-fn" rid="table-fn2-1757177413476125">*</xref></td>
<td>0.52±0.20</td>
<td>0.39±0.04</td>
<td>0.78±0.13</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1757177413476125">
<p>Note: *, indicates no data due to poor performance at lower level of interference</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of conflicting interests</label>
<p>P. Finan is a director of MTP Innovations Ltd.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work was partially funded by MTP Innovations Ltd.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ali</surname><given-names>S</given-names></name>
<name><surname>Moore</surname><given-names>G</given-names></name>
<name><surname>Wilson</surname><given-names>APR</given-names></name>
</person-group>. (<year>2011</year>) <article-title>Spread and persistence of <italic>Clostridium difficile</italic> spores during and after cleaning with sporicidal disinfectants</article-title>. <source>Journal of Hospital Infection</source> <volume>79</volume>: <fpage>97</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr2-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Bailey</surname><given-names>M</given-names></name>
</person-group>. (<year>2009</year>) <source>Infection prevention and control policy manual, Section 4 – Decontamination</source>. <publisher-name>University Hospital of South Manchester</publisher-name>: <publisher-loc>Manchester, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr3-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Bloomfield</surname><given-names>J</given-names></name>
</person-group>. (<year>2011</year>) <source>Cleaning policy for infected ward areas</source>. <publisher-name>Royal United Hospital</publisher-name>, <publisher-loc>Bath, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr4-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>1997</year>) <source>BSEN 1276:1997. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr5-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>2001</year>) <source>BS EN 13697:2001. Chemical disinfectants and antiseptics. Quantitative non-porous surface test for the evaluation of bactericidal and/or fungicidal or yeasticidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr6-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>2002</year>) <source>BSEN 13704:2002. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic, and institutional areas</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr7-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>2005</year>) <source>BS EN 14348:2005. Quantitative suspension test for the evaluation of mycobactericidal activity of chemical disinfectants in the medical area including instrument disinfectants</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr8-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>2006</year>) <source>BS EN 14885:2006, Application of European Standards for chemical disinfectants and antiseptics</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr9-1757177413476125">
<citation citation-type="book">
<collab>BSI</collab>. (<year>2008</year>) <source>BS EN 1650:2008. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of fungicidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas</source>. <publisher-name>British Standards Institute</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr10-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carling</surname><given-names>PC</given-names></name>
<name><surname>Bartley</surname><given-names>JM</given-names></name>
</person-group>. (<year>2010</year>) <article-title>Evaluating hygienic cleaning in health care settings: what you do not know can harm your patients</article-title>. <source>American Journal of Infection Control</source> <volume>38</volume>: <fpage>S41</fpage>–<lpage>S50</lpage>.</citation>
</ref>
<ref id="bibr11-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carter</surname><given-names>Y</given-names></name>
<name><surname>Barry</surname><given-names>D</given-names></name>
</person-group> (<year>2011</year>). <article-title>Tackling <italic>C difficile</italic> with environmental cleaning</article-title>. <source>Nursing Times</source> <volume>107</volume>: <fpage>22</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr12-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clasen</surname><given-names>T</given-names></name>
<name><surname>Edmondson</surname><given-names>P</given-names></name>
</person-group>. (<year>2006</year>) <article-title>Sodium dichloroisocyanurate (NaDCC) tablets as an alternative to sodium hypochlorite for the routine treatment of drinking water at the household level</article-title>. <source>International Journal of Hygiene and Environmental Health</source> <volume>209</volume>: <fpage>173</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr13-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dancer</surname><given-names>SJ</given-names></name>
</person-group>. (<year>2009</year>) <article-title>The role of environmental cleaning in the control of hospital-acquired infection</article-title>. <source>Journal of Hospital Infection</source> <volume>73</volume>: <fpage>378</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr14-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dancer</surname><given-names>SJ</given-names></name>
<name><surname>Carling</surname><given-names>PC</given-names></name>
</person-group>. (<year>2010</year>). <article-title>All that glistens may be neither gold nor clean</article-title>. <source>Journal of Hospital Infection</source> <volume>76</volume>: <fpage>177</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr15-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dancer</surname><given-names>SJ</given-names></name>
<name><surname>White</surname><given-names>LF</given-names></name>
<name><surname>Lamb</surname><given-names>J</given-names></name>
<name><surname>Kirsty</surname><given-names>KE</given-names></name>
<name><surname>Robertson</surname><given-names>C</given-names></name>
</person-group>. (<year>2009</year>) <article-title>Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study</article-title>. <source>BMC Medicine</source> <volume>7</volume>.</citation>
</ref>
<ref id="bibr16-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davies</surname><given-names>DM</given-names></name>
<name><surname>Deary</surname><given-names>ME</given-names></name>
</person-group>. (<year>1991</year>) <article-title>Kinetics of the hydrolysis and perhydrolysis of tetraacetylethylenediamine, a peroxide bleach activator</article-title>. <source>Journal of the Chemical Society, Perkin Transactions</source> <volume>2</volume>: <fpage>1549</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr17-1757177413476125">
<citation citation-type="book">
<collab>Department of Health</collab>. (<year>1998</year>) <source>Guidance for clinical health care workers</source>. <publisher-name>Department of Health</publisher-name>: <publisher-loc>Wetherby, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr18-1757177413476125">
<citation citation-type="book">
<collab>Department of Health and Health Protection Agency</collab>. (<year>2009</year>) <source>Clostridium difficile infection: how to deal with the problem</source>: <publisher-name>DH Publications</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr19-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Eaton</surname><given-names>AD</given-names></name>
<name><surname>Clesceri</surname><given-names>LS</given-names></name>
<name><surname>Rice</surname><given-names>EW</given-names></name>
<name><surname>Greenberg</surname><given-names>AE</given-names></name>
</person-group>. (<year>2005</year>) <source>Standard methods for the examination of water and wastewater</source>. <edition>21st edn</edition>. <publisher-name>APHA</publisher-name>, <publisher-loc>USA</publisher-loc>.</citation>
</ref>
<ref id="bibr20-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fawley</surname><given-names>W</given-names></name>
<name><surname>Underwood</surname><given-names>S</given-names></name>
<name><surname>Freeman</surname><given-names>J</given-names></name>
<name><surname>Baines</surname><given-names>S</given-names></name>
<name><surname>Saxton</surname><given-names>B</given-names></name>
<name><surname>Stephenson</surname><given-names>K</given-names></name>
<name><surname>Owens</surname><given-names>R</given-names></name>
<name><surname>Wilcox</surname><given-names>M</given-names></name>
</person-group>. (<year>2007</year>) <article-title>Efficacy of hospital cleaning agents and germicides against epidemic <italic>Clostridium difficile</italic> strains</article-title>. <source>Infection Control and Hospital Epidemiology</source> <volume>28</volume>: <fpage>920</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr21-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fraise</surname><given-names>A</given-names></name>
</person-group>. (<year>2011</year>) <article-title>Currently available sporicides for use in healthcare, and their limitations</article-title>. <source>Journal of Hospital Infection</source> <volume>77</volume>: <fpage>210</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr22-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Fraise</surname><given-names>AP</given-names></name>
<name><surname>Lambert</surname><given-names>PA</given-names></name>
<name><surname>Maillard</surname><given-names>J-Y</given-names></name>
</person-group>. (<year>2004</year>) <source>Russell, Hugo and Ayliffe’s principles and practice of disinfection preservation and sterilisation</source>. <publisher-name>Blackwell Publishing</publisher-name>: <publisher-loc>Oxford, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr23-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gant</surname><given-names>VA</given-names></name>
<name><surname>Jeanes</surname><given-names>A</given-names></name>
<name><surname>Hall</surname><given-names>TJ</given-names></name>
</person-group> (<year>2010</year>). <article-title>Response to: Griffith CJ, Dancer SJ. Hospital cleaning: problems with steam cleaning and microfibre</article-title>. <source>Journal of Hospital Infection</source> <volume>74</volume>: <fpage>82</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr24-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goldenberg</surname><given-names>SD</given-names></name>
<name><surname>Patel</surname><given-names>A</given-names></name>
<name><surname>Tucker</surname><given-names>D</given-names></name>
<name><surname>French</surname><given-names>GL</given-names></name>
</person-group>. (<year>2012</year>) <article-title>Lack of enhanced effect of a chlorine dioxide-based cleaning regimen on environmental contamination with <italic>Clostridium difficile</italic> spores</article-title>. <source>Journal of Hospital Infection</source> <volume>82</volume>: <fpage>64</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr25-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Greenspan</surname><given-names>FP</given-names></name>
<name><surname>MacKellar</surname><given-names>DG</given-names></name>
</person-group> (<year>1948</year>). <article-title>Analysis of aliphatic per acids</article-title>. <source>Analytical Chemistry</source> <volume>20</volume>: <fpage>1061</fpage>–<lpage>3</lpage>.</citation>
</ref>
<ref id="bibr26-1757177413476125">
<citation citation-type="book">
<collab>Health Protection Agency (HPA)</collab> (<year>2012</year>). <source>Processing of faeces for Clostridium difficile. UK Standards for Microbiology Investigations</source>. <publisher-name>Standards Unit, Microbiology Services Division, HPA</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr27-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hernández</surname><given-names>A</given-names></name>
<name><surname>Martró</surname><given-names>E</given-names></name>
<name><surname>Matas</surname><given-names>L</given-names></name>
<name><surname>Ausina</surname><given-names>V</given-names></name>
</person-group> (<year>2003a</year>) <article-title>In-vitro evaluation of Perasafe® compared with 2% alkaline glutaraldehyde against Mycobacterium spp</article-title>. <source>Journal of Hospital Infection</source> <volume>54</volume>: <fpage>52</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr28-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hernández</surname><given-names>A</given-names></name>
<name><surname>Martró</surname><given-names>E</given-names></name>
<name><surname>Puzo</surname><given-names>C</given-names></name>
<name><surname>Matas</surname><given-names>L</given-names></name>
<name><surname>Burgués</surname><given-names>C</given-names></name>
<name><surname>Vázquez</surname><given-names>N</given-names></name>
<name><surname>Castella</surname><given-names>J</given-names></name>
<name><surname>Ausina</surname><given-names>V</given-names></name>
</person-group> (<year>2003b</year>). <article-title>In-use evaluation of Perasafe® compared with Cidex® in fibreoptic bronchoscope disinfection</article-title>. <source>Journal of Hospital Infection</source> <volume>54</volume>: <fpage>46</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr29-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Humphreys</surname><given-names>PN</given-names></name>
</person-group>. (<year>2011</year>) <article-title>Testing standards for sporicides</article-title>. <source>Journal of Hospital Infection</source> <volume>77</volume>: <fpage>193</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr30-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>KH</given-names></name>
<name><surname>Fekety</surname><given-names>R</given-names></name>
<name><surname>Batts</surname><given-names>DH</given-names></name>
<name><surname>Brown</surname><given-names>D</given-names></name>
<name><surname>Cudmore</surname><given-names>M</given-names></name>
<name><surname>Silva</surname><given-names>J</given-names></name>
<name><surname>Waters</surname><given-names>D</given-names></name>
</person-group>. (<year>1981</year>) <article-title>Isolation of <italic>Clostridium difficile</italic> from the environment and contacts of patients with antibiotic-associated colitis</article-title>. <source>Journal of Infectious Diseases</source> <volume>143</volume>: <fpage>42</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr31-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>A</given-names></name>
<name><surname>Schwebk</surname><given-names>I</given-names></name>
<name><surname>Kampf</surname><given-names>G</given-names></name>
</person-group>. (<year>2006</year>) <article-title>How long do nosocomial pathogens persist on inanimate surfaces? A systematic review</article-title>. <source>BMC Infectious Diseases</source> <volume>6</volume>: <fpage>130</fpage>.</citation>
</ref>
<ref id="bibr32-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Lambert</surname><given-names>PA</given-names></name>
</person-group>. (<year>2004</year>) <article-title>Resistance of bacterial spores to chemical agents</article-title>. In: <person-group person-group-type="editor">
<name><surname>Fraise</surname><given-names>AP</given-names></name>
<name><surname>Lambert</surname><given-names>PA</given-names></name>
<name><surname>Maillard</surname><given-names>J-Y</given-names></name>
</person-group> (eds) <source>Russell, Hugo &amp; Ayliffe’s principles and practice of disinfection, preservation and sterilization</source>. <publisher-name>John Wiley and Sons</publisher-name>: <publisher-loc>New York</publisher-loc>.</citation>
</ref>
<ref id="bibr33-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maillard</surname><given-names>J-Y</given-names></name>
</person-group>. (<year>2011</year>) <article-title>Innate resistance to sporicides and potential failure to decontaminate</article-title>. <source>Journal of Hospital Infection</source> <volume>77</volume>: <fpage>204</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr34-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malamou-Ladas</surname><given-names>H</given-names></name>
<name><surname>O’Farrell</surname><given-names>S</given-names></name>
<name><surname>Nash</surname><given-names>JQ</given-names></name>
<name><surname>Tabaqchali</surname><given-names>S</given-names></name>
</person-group>. (<year>1983</year>) <article-title>Isolation of <italic>Clostridium difficile</italic> from patients and the environment of hospital wards</article-title>. <source>Journal of Clinical Pathology</source> <volume>36</volume>: <fpage>88</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr35-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McDonnell</surname><given-names>G</given-names></name>
<name><surname>Russell</surname><given-names>AD</given-names></name>
</person-group>. (<year>1999</year>) <article-title>Antiseptics and disinfectants: activity, action, and resistance</article-title>. <source>Clinical Microbiology Reviews</source> <volume>12</volume>: <fpage>147</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr36-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mulligan</surname><given-names>ME</given-names></name>
<name><surname>Rolfe</surname><given-names>RD</given-names></name>
<name><surname>Finegold</surname><given-names>SM</given-names></name>
<name><surname>George</surname><given-names>WL</given-names></name>
</person-group>. (<year>1979</year>) <article-title>Contamination of a hospital environment by <italic>Clostridium difficile</italic></article-title>. <source>Current Microbiology</source> <volume>3</volume>: <fpage>173</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr37-1757177413476125">
<citation citation-type="book">
<collab>National Patient Safety Agency</collab>. (<year>2009</year>) <source>The revised healthcare cleaning manual</source>. <publisher-name>National Patient Safety Agency, National Reporting and Learning Service, NHS</publisher-name>: <publisher-loc>London, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr38-1757177413476125">
<citation citation-type="book">
<collab>NHS Wirral</collab>. (<year>2010</year>) <source>Cleaning and disinfection policy</source>. <publisher-name>NHS Wirral</publisher-name>: <publisher-loc>NHS UK</publisher-loc>.</citation>
</ref>
<ref id="bibr39-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Niknejad</surname><given-names>F</given-names></name>
<name><surname>Morady</surname><given-names>MS</given-names></name>
<name><surname>Keshtkar</surname><given-names>AA</given-names></name>
<name><surname>Joshaghani</surname><given-names>HR</given-names></name>
<name><surname>Mardani</surname><given-names>A</given-names></name>
<name><surname>Moazeni</surname><given-names>M</given-names></name>
</person-group>. (<year>2011</year>) <article-title>In vitro evaluation of antifungal activity of peroxy acetic acid component (Percidine) on a group of fungi</article-title>. <source>Microbiology Journal</source> <volume>1</volume>: <fpage>40</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr40-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Otter</surname><given-names>JA</given-names></name>
<name><surname>Yezli</surname><given-names>S</given-names></name>
<name><surname>French</surname><given-names>GL</given-names></name>
</person-group>. (<year>2011</year>). <article-title>The role played by contaminated surfaces in the transmission of nosocomial pathogens</article-title>. <source>Infection Control and Hospital Epidemiology</source> <volume>32</volume>: <fpage>687</fpage>–<lpage>99</lpage></citation>
</ref>
<ref id="bibr41-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pan</surname><given-names>GX</given-names></name>
<name><surname>Spencer</surname><given-names>L</given-names></name>
<name><surname>Leary</surname><given-names>GJ</given-names></name>
</person-group>. (<year>1999</year>) <article-title>Reactivity of ferulic acid and its derivatives toward hydrogen peroxide and peracetic acid</article-title>. <source>Journal of Agricultural and Food Chemistry</source> <volume>47</volume>: <fpage>3325</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr42-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pratt</surname><given-names>RJ</given-names></name>
<name><surname>Pellowe</surname><given-names>CM</given-names></name>
<name><surname>Wilson</surname><given-names>JA</given-names></name>
<name><surname>Loveday</surname><given-names>HP</given-names></name>
<name><surname>Harper</surname><given-names>PJ</given-names></name>
<name><surname>Jones</surname><given-names>SR</given-names></name>
<name><surname>McDougall</surname><given-names>C</given-names></name>
<name><surname>Wilcox</surname><given-names>MH</given-names></name>
</person-group>. (<year>2007</year>) <article-title>epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England</article-title>. <source>Journal of Hospital Infection</source> <volume>65</volume> (<supplement>Suppl 1</supplement>): <fpage>S1</fpage>–<lpage>S59</lpage>.</citation>
</ref>
<ref id="bibr43-1757177413476125">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Russell</surname><given-names>AD</given-names></name>
</person-group>. (<year>2004</year>). <article-title>Factors influencing the efficacy of antimicrobial agents</article-title>. In: <person-group person-group-type="editor">
<name><surname>Fraise</surname><given-names>AP</given-names></name>
<name><surname>Lambert</surname><given-names>PA</given-names></name>
<name><surname>Maillard</surname><given-names>J-Y</given-names></name>
</person-group> (eds) <source>Russell, Hugo and Ayliffe’s principles and practice of disinfection preservation and sterilisation</source>, <edition>4th edn.</edition> <publisher-name>Blackwell Publishing</publisher-name>: <publisher-loc>Oxford, UK</publisher-loc>.</citation>
</ref>
<ref id="bibr44-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sambol</surname><given-names>SP</given-names></name>
<name><surname>Tang</surname><given-names>JK</given-names></name>
<name><surname>Merrigan</surname><given-names>MM</given-names></name>
<name><surname>Johnson</surname><given-names>S</given-names></name>
<name><surname>Gerding</surname><given-names>DN</given-names></name>
</person-group>. (<year>2001</year>). <article-title>Infection of hamsters with epidemiologically important strains of <italic>Clostridium difficile</italic></article-title>. <source>Journal of Infectious Diseases</source> <volume>183</volume>: <fpage>1760</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr45-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sisti</surname><given-names>M</given-names></name>
<name><surname>Brandi</surname><given-names>G</given-names></name>
<name><surname>Santi</surname><given-names>MD</given-names></name>
<name><surname>Rinaldi</surname><given-names>L</given-names></name>
<name><surname>Schiavano</surname><given-names>GF</given-names></name>
</person-group>. (<year>2012</year>). <article-title>Disinfection efficacy of chlorine and peracetic acid alone or in combination against <italic>Aspergillus</italic> spp. and <italic>Candida albicans</italic> in drinking water</article-title>. <source>Journal of Water and Health</source> <volume>10</volume>: <fpage>11</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr46-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Speight</surname><given-names>S</given-names></name>
<name><surname>Moy</surname><given-names>A</given-names></name>
<name><surname>Macken</surname><given-names>S</given-names></name>
<name><surname>Chitnis</surname><given-names>R</given-names></name>
<name><surname>Hoffman</surname><given-names>PN</given-names></name>
<name><surname>Davies</surname><given-names>A</given-names></name>
<name><surname>Bennett</surname><given-names>A</given-names></name>
<name><surname>Walker</surname><given-names>JT</given-names></name>
</person-group>. (<year>2011</year>) <article-title>Evaluation of the sporicidal activity of different chemical disinfectants used in hospitals against <italic>Clostridium difficile</italic></article-title>. <source>Journal of Hospital Infection</source> <volume>79</volume>: <fpage>18</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr47-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tumah</surname><given-names>HN</given-names></name>
</person-group>. (<year>2009</year>) <article-title>Bacterial biocide resistance</article-title> <source>Journal of Chemotherapy</source> <volume>21</volume>: <fpage>5</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr48-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vizcaino-Alcaide</surname><given-names>MJ</given-names></name>
<name><surname>Herruzo-Cabrera</surname><given-names>R</given-names></name>
<name><surname>Fernandez-Aceñero</surname><given-names>MJ</given-names></name>
</person-group>. (<year>2003</year>). <article-title>Comparison of the disinfectant efficacy of Perasafe® and 2% glutaraldehyde in in vitro tests</article-title>. <source>Journal of Hospital Infection</source> <volume>53</volume>: <fpage>124</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr49-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vohra</surname><given-names>P</given-names></name>
<name><surname>Poxton</surname><given-names>IR</given-names></name>
</person-group>. (<year>2011</year>). <article-title>Efficacy of decontaminants and disinfectants against <italic>Clostridium difficile</italic></article-title>. <source>Journal of Medical Microbiology</source> <volume>60</volume>: <fpage>1218</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr50-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>YL</given-names></name>
<name><surname>Chen</surname><given-names>WC</given-names></name>
<name><surname>Chen</surname><given-names>YY</given-names></name>
<name><surname>Tseng</surname><given-names>SH</given-names></name>
<name><surname>Chien</surname><given-names>LJ</given-names></name>
<name><surname>Wu</surname><given-names>HS</given-names></name>
<name><surname>Chiang</surname><given-names>CS</given-names></name>
</person-group>. (<year>2010</year>) <article-title>Bacterial contamination on surfaces of public areas in hospitals</article-title>. <source>Journal of Hospital Infection</source> <volume>74</volume>: <fpage>195</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr51-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weber</surname><given-names>DJ</given-names></name>
<name><surname>Rutala</surname><given-names>WA</given-names></name>
<name><surname>Miller</surname><given-names>MB</given-names></name>
<name><surname>Huslage</surname><given-names>K</given-names></name>
<name><surname>Sickbert-Bennett</surname><given-names>E</given-names></name>
</person-group>. (<year>2010</year>). <article-title>Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, <italic>Clostridium difficile</italic>, and <italic>Acinetobacter</italic> species</article-title>. <source>American Journal of Infection Control</source> <volume>38</volume>: <fpage>S25</fpage>–<lpage>S33</lpage>.</citation>
</ref>
<ref id="bibr52-1757177413476125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Whitehead</surname><given-names>KA</given-names></name>
<name><surname>Deisenroth</surname><given-names>T</given-names></name>
<name><surname>Preuss</surname><given-names>A</given-names></name>
<name><surname>Liauw</surname><given-names>CM</given-names></name>
<name><surname>Verran</surname><given-names>J</given-names></name>
</person-group>. (<year>2011</year>). <article-title>The effect of surface properties on the strength of attachment of fungal spores using AFM perpendicular force measurements</article-title>. <source>Colloids and Surfaces B: Biointerfaces</source> <volume>82</volume>: <fpage>483</fpage>–<lpage>9</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>